EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II

Shuang Tian, Chao Liu iD, Jie Wu iD

Journal of Translational Internal Medicine · 02.11.2026 · 14 (5) · 842-845

DOI: 10.1515/jtim-2026-0069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 24.08.2026. Verfasst von Shuang Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Genetics, Basic Medical College, Jinzhou Medical University, Jinzhou, Liaoning Province, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Cell Biology and Genetics, Basic Medical College, Jinzhou Medical University, Jinzhou, Liaoning Province, China.
  • Liaoning Province Key Laboratory of Human Phenome Research, Jinzhou Medical University, Jinzhou, Liaoning Province, China.
  • School of Public Health, Shenyang Medical College, Shenyang, Liaoning Province, China.
  • Liaoning Medical Functional Food Professional Technology Innovation Center, Shenyang Medical College, Shenyang, Liaoning Province, China.

ORCID-Profile: Chao Liu, Jie Wu

Zitieren

APA

Tian, S., Liu, C., & Wu, J. (2026). Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II. Journal of Translational Internal Medicine, 14(5), 842-845. https://doi.org/10.1515/jtim-2026-0069

Vancouver

Tian S, Liu C, Wu J. Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II. Journal of Translational Internal Medicine. 2026;14(5):842-845. doi:10.1515/jtim-2026-0069

BibTeX
@article{Tian2026,
  author = {Tian, Shuang and Liu, Chao and Wu, Jie},
  title = {Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II},
  journal = {Journal of Translational Internal Medicine},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {842--845},
  doi = {10.1515/jtim-2026-0069}
}
Kostenlos starten →